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Abstract
Background: Blastomere injection of mRNA or antisense oligonucleotides has proven effective
in analyzing early gene function in Xenopus. However, functional analysis of genes involved in
neuronal differentiation and axon pathfinding by this method is often hampered by earlier function
of these genes during development. Therefore, fine spatio-temporal control of over-expression or
knock-down approaches is required to specifically address the role of a given gene in these
processes.
Results: We describe here an electroporation procedure that can be used with high efficiency and
low toxicity for targeting DNA and antisense morpholino oligonucleotides (MOs) into spatially
restricted regions of the Xenopus CNS at a critical time-window of development (22–50 hour post-
fertilization) when axonal tracts are first forming. The approach relies on the design of
"electroporation chambers" that enable reproducible positioning of fixed-spaced electrodes
coupled with accurate DNA/MO injection. Simple adjustments can be made to the electroporation
chamber to suit the shape of different aged embryos and to alter the size and location of the
targeted region. This procedure can be used to electroporate separate regions of the CNS in the
same embryo allowing separate manipulation of growing axons and their intermediate and final
targets in the brain.
Conclusion: Our study demonstrates that electroporation can be used as a versatile tool to
investigate molecular pathways involved in axon extension during Xenopus  embryogenesis.
Electroporation enables gain or loss of function studies to be performed with easy monitoring of
electroporated cells. Double-targeted transfection provides a unique opportunity to monitor axon-
target interaction in vivo. Finally, electroporated embryos represent a valuable source of MO-
loaded or DNA transfected cells for in vitro analysis. The technique has broad applications as it can
be tailored easily to other developing organ systems and to other organisms by making simple
adjustments to the electroporation chamber.
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Background
Xenopus laevis is a model system widely used to study ver-
tebrate development. Much of our understanding of early
embryo patterning and tissue induction has come from
this model, and Xenopus has provided many important
insights into neuronal development. However, many of
the molecules involved in neuronal differentiation also
play crucial roles in early development [1,2]. Therefore,
the classical approach of injecting blastomeres with DNA/
mRNA or antisense oligonucleotides (morpholinos,
MOs) is of limited use for studying axon guidance as it
interferes with gene function during early development
and frequently leads to abnormal embryogenesis. In some
cases, this problem can be circumvented by the use of
inducible or tissue specific promoters [3-6] but selective
expression during a specific time-window in selected pop-
ulations of cells remains difficult and levels of expression
often decrease with time due to plasmid dilution during
cell division [7,8]. Ideally, to test the function of a specific
molecule in axon guidance, its function should be dis-
rupted exclusively during the period of axonogenesis. To
this end, lipofection has proven useful to introduce DNA
in the developing eye and brain of stage 19–24 Xenopus
embryos [8,9] and viral infection using vaccina virus has
also been used in stage 40–48 Xenopus embryos [10,11].
However, each of these techniques has drawbacks, such as
the low efficiency of transfection of lipofection and the
low expression level and reproducibility of vaccinia viral
infection [12]. Electroporation does not suffer from these
limitations. Indeed, its ease of use combined with efficient
and accurate spatio-temporal targeting quickly estab-
lished electroporation as superior to most other methods
of genetic manipulations in chick embryos [13-16].
In addition to DNA and RNA, electroporation can be used
to deliver dsRNA, RNAi, antisense morpholinos (MO),
dyes and proteins [17-21]. This large repertoire and the
ability to introduce several types of molecules at the same
time have provided new paradigms for monitoring gene
expression, cell morphology, movements and lineage, as
well as efficient means for interfering with protein and
microRNA function [13,19,22-25]. As a result, chick elec-
troporation has made major contributions to the under-
standing of gene regulation, cell proliferation, migration
and differentiation, and more generally of the underlying
mechanism of nervous system patterning and neuronal
wiring [13,22,26-28]. Electroporation methods have now
been adapted for use in many animal models including
mouse [13,29], rat [29], zebrafish [30,31], ascidian [32],
hydra [33] and drosophila [34]. In Xenopus, electroporation
has been successfully used to introduce DNA into the
brains of late tadpole embryos (stages 44–48) [10,12,35]
and RNA into the CNS of early neurula embryos (stage
12.5) [36,37]. Although a previous study reports that
stage 25–29/30 embryos can be successfully electroper-
meablized [38], electroporation has only been used dur-
ing this developmental window to enhance lipofection
[39]. Thus, no electroporation protocol has been
described for the intermediate developmental ages (stages
21–40) that span the critical 40 h window of brain wiring,
when most of the major axon tracts are formed in the
Xenopus CNS [40-44].
We describe here a detailed electroporation procedure to
introduce efficiently both DNA and MOs to restricted
regions of the brain and eye between stages 21 and 35/36.
This protocol relies on the design of "electroporation
chambers", tailored to individual embryonic stages,
which allows reproducible and efficient large or targeted
electroporation of different regions of the CNS. We dem-
onstrate that projection neurons and their targets, both
intermediate and final, can be selectively manipulated by
multiple targeted electroporations or a combination of
electroporation and lipofection. As such, electroporation
can be a reliable and efficient tool to examine gene func-
tion during CNS differentiation. Finally, we provide evi-
dence of the potential benefits of electroporation for the
study of axonogenesis in vitro.
Results and discussion
Electroporation chambers enable reproducible and 
efficient electroporation
Efficient and reproducible electroporation relies primarily
on the precision of the injection of DNA. To control injec-
tion accuracy, stage 21–35/36 embryos must be held in
the desired position and submerged in a drop of medium,
as they easily deform and are highly sensitive to drying.
Previously published electroporation procedures could
not be used because they do not permit accurate orienta-
tion of the embryos [38] nor take into account the soft-tis-
sue vulnerability or morphology of the targeted stages
[12,36]. Therefore, we developed electroporation cham-
bers tailored individually to the size and morphology of
embryos from stages 21 to 35/36. The basic design of the
chambers consists of two channels carved perpendicular
to one another in Sylgard in the shape of a cross (Figure
1a). The embryo is held in the longitudinal channel while
the electrodes are placed in the transverse channel. The
size and geometry of the longitudinal channel was opti-
mized for each embryonic stage to provide a "snug fit" for
the embryo and full immersion in medium. The position
of the transverse channel insures reproducible placement
of the electrodes along the anterior-posterior axis of the
embryo and its depth controls the amount of electrode
surface in contact with the medium, and thus the dorso-
ventral extent of the embryo exposed to the electric field.
The length of the transverse channel is designed so that
when electrodes are placed at each end, electroporation
efficiency is maximized while damage to the embryo is
minimized. In addition, the spacing and immobilizationBMC Developmental Biology 2007, 7:107 http://www.biomedcentral.com/1471-213X/7/107
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Efficient DNA transfection of stage 26–28 Xenopus embryos Figure 1
Efficient DNA transfection of stage 26–28 Xenopus embryos. a: Schematic representation of the experimental setup. 
Embryos were placed in the main channel of the electroporation chamber, while the electrode tips (0.5 mm wide) were posi-
tioned in the transverse channel. A diagram of the setup is presented as an insert with channel (outlines in red). b, c: Repre-
sentative images of embryos electroporated in 1× MMR and 0.1× MBS. Bright field images (left panel) and GFP fluorescence 
(right panel) of living embryos 12 h after electroporation. No morphological abnormalities are observed. d: Histograms pre-
senting the relative transfection efficiencies (blue) evaluated from observation of embryos as shown in c and d. The percentage 
of embryos showing macroscopic damage (red) was recorded for each condition. Different parameters are listed in the follow-
ing order: Voltage, pulse duration, interpulse space and number of pulses. e, f: Electroporation resulted in a high percentage of 
transfected cells without affecting brain microanatomy. Nls-GFP signal (e) was observed in many nuclei (f) from the ventricle to 
the most superficial layer 48 h after electroporation. The transfected hemi-brain was outlined in white. Scale bars: 400 µm in b 
and c; 100 µm in e.
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of the electrodes in the transverse channel enable accurate
positioning prior to injection. This allows the electric field
to be applied immediately after DNA injection which is
critical for minimizing diffusion and backflow of the
injected solution through the opening made by the capil-
lary [19,45,46].
Electroporation leads to efficient transfection in Xenopus
To determine the optimal conditions for Xenopus electro-
poration, voltage, frequency and duration of electrical
pulses were systematically varied using the experimental
set-up illustrated in Figure 1a (embryos were kept at
18°C). 93% of the embryos (n = 34) injected at stage 26–
28 into the third ventricle with a solution containing 1 µg/
µl of green fluorescent protein (GFP) encoding plasmids
exhibited bright GFP expression 12 h after being exposed
to 8 square-pulses of 20 V 50 ms applied every second (20
V/50 ms/1 s/8 x) (Figure 1b). Efficient transfection
required a high conductivity electroporation medium as
the success rate dropped 2.5-fold (n = 26) when 0.1×
Modified Barth's Saline (MBS) was used instead of 1×
MBS or 1× Modified Modified Ringer's (MMR) (Figure 1b
and 1c). The high conductance of the medium surround-
ing the low conducting embryo could enhance electropo-
ration by preventing the decrease of electric field inside
the embryo as shown on cellular spheroids [47]. As sum-
marized in Figure 1d (blue), a series of 4 or more 15–20 V
pulses with a duration of 25–100 ms each led to >60%
electroporation success rate. Electroporation efficiency
consistently increased in proportion to pulse number,
voltage and duration (when below 200 ms). A decrease in
voltage or pulse duration could be partially compensated
for by increasing the number of pulses.
To further characterize the efficiency of electroporation,
nucleus-targeted GFP (nls-GFP) was transfected to quan-
tify the fraction of GFP-expressing versus non-expressing
cells on transverse brain sections counterstained with a
nuclear stain (DAPI). 48 h after electroporation (20 V/50
ms/1 s/8 x), the average fraction of cells expressing GFP
per section was 47.1 ± 2.5% in the transfected region (n =
47 sections 6 embryos; Figure 1e and 1f). Transfected cells
were scattered along 50–70% of the dorso-ventral axis and
throughout the whole neuroepithelium. At this stage, the
brain comprises a proliferative region adjacent to the ven-
tricle lumen (ventricular zone) surrounded by layers of
migrating and differentiating neurons (mantle zone). 48
h post-electroporation, transfected cells were present in
both regions. GFP-expressing cells residing in the superfi-
cial third of the brain, populated by differentiated neu-
rons, represented 31.8 ± 1.5% of total labeled cells (n =
32). However, the fraction of transfected cells in the
superficial half of the brain increased with pulse duration
(see additional file 1 a & b). To check the morphology of
transfected cells and further characterize their cell types,
we transfected membrane-targeted GFP or RFP (GAP-GFP
and -RFP). As expected, the GFP signal was found from the
ventricle to the neuropil (Figure 2a). Cells lining the ven-
tricle could be seen extending radial process towards the
pia, typical of dividing cells (Figure 2b). Transfected neu-
rons appeared to differentiate normally as they expressed
the neuronal marker acetylated tubulin, and sent long
processes into the neuropil (Figure 2c–e). Furthermore,
several axon tracts could be recognized in a whole-mount
view of the brain (Figure 2f).
Finally, we assayed the potential adverse side effects of
electroporation. Electroporation did not increase either
the embryo death rate or the occurrence of morphological
abnormalities, provided the pulse voltage remained under
25 V and the pulse duration under 100 ms (Figure 1d red).
The anatomy of the embryos and their brains appeared
normal on transverse sections at all time points after elec-
troporation tested (Figure 1f). Some pyknotic nuclei were
observed in highly transfected embryos in the first 24 h
post-electroporation. Therefore, TUNEL staining was used
to assess cell death on sections. 24 h after exposure to 20
V/50 ms/1 s/8 x and 18 V/25 ms/1 s/10 x, the average
number of TUNEL positive cells per section was 5.21 ±
0.35 (n = 48) and 2.8 ± 0.48 (n = 28) respectively (see
additional file 1g). This compares favorably with an aver-
age of 3.5 ± 0.27 cells/section (n = 63) in control embryos
and indicates that the electric pulses are relatively harm-
less per se. However, other parameters such as DNA purity,
embryo quality, manipulation and injection are critical
for minimizing cell death. Thus, electroporation of ven-
tricular injected DNA led to efficient transfection of both
the dividing ventricular region and differentiated neurons
without increasing cell death or affecting their morpho-
logical differentiation.
Electroporation at different stages produces rapid and 
long-lasting transgene expression
Neuronal differentiation and initial establishment of the
major axonal projections progress rapidly from stage 20 to
40 and, during this period, the neuroepithelium under-
goes major reorganization with post-mitotic neurons
migrating away from the ventricular surface to the super-
ficial layers. To achieve fine temporal resolution, the elec-
troporation procedure should be similarly efficient across
different time-windows. Therefore, we compared the effi-
ciency of the electroporation protocol over different
stages.
Embryos were electroporated following intraventricular
pCS2GFP-DNA injection at stages ranging from 21 to 35/
36 in chambers specially adapted to their morphology.
External inspection of embryos under the fluorescent
strereomicroscope showed that the fraction of embryos
exhibiting bright GFP expression 12 h after electropora-BMC Developmental Biology 2007, 7:107 http://www.biomedcentral.com/1471-213X/7/107
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tion was >70%, regardless of the stage at which the elec-
troporation was performed. Despite these similar levels at
a gross level, analysis of the GFP positive cell fraction (nls-
GFP) on transverse sections revealed that a sharp decrease
in efficiency occurs at stage 32 (Figure 3a). In addition, the
GFP-expressing cells from late (stage 32) electroporations
were distributed unevenly in the neuroepithelium. First,
there was a marked decline in the number of transfected
cells in the ventral brain. Indeed, the dorsal shift of the
GFP-expression center of mass (relative to the DAPI
nuclear marker) significantly increased 1.5-fold between
stages 28 and 32. Secondly, 48 h after electroporation,
fewer GFP-positive cells can be found in the superficial
region of the neuroepithelium closest to the pia (Figure
3b–d). Several factors may contribute to the observed
changes. As the brain develops, the ventricle lumen
expands and post-mitotic cells migrate away from the ven-
tricular surface to differentiate in superficial layers. Conse-
quently, many cells are distant to the injection site,
making them less likely to be transfected. In addition, a
larger ventricle means a lower intraventricular concentra-
tion of injected DNA, which will restrict the transfection
to cells lining the ventricle and decrease the electropora-
tion efficiency overall. In agreement with this, doubling
the injection volume enhances the electroporation success
rate by 1.25 (assessed as in figure 1b; n = 12). However, if
the local DNA concentration was the only factor involved,
a stage-dependent distribution of GFP positive cells
would be expected shortly after electroporation. In fact,
12 h after electroporation the fraction of GFP positive cells
located in the superficial half of the brain was similar in
embryos electroporated at stage 28 and 32 (24.4 ± 1.6, n
= 36 and 21.9 ± 2.1, n = 20 sections respectively). The
delayed onset of the stage-dependent difference in deep-
superficial distribution suggests that it results at least
partly from developmental changes in patterns of cell pro-
liferation and migration that occur after electroporation.
In order to gain access to the cells situated close to the pia,
we delivered DNA to the pial surface by injecting under
the skin epidermis instead of intraventricularly (stage 29/
30 embryos). Subcutaneous injections, followed immedi-
ately by electroporation, efficiently and selectively trans-
fected cells in superficial layers of the brain (Figure 3e).
Overall, GFP expression in embryos electroporated
between stages 21 to 35/36 displayed similar kinetics. In
whole embryos, the GFP signal can first be detected 5–6 h
after electroporation. This signal progressively intensifies
and spreads over the subsequent 36 h, and remains high
for several days. Nuclear GFP was used to quantify the
GFP expression at different time points on transverse sec-
tions of embryos electroporated at stage 29/30. A progres-
sive increase in both the fraction and the average intensity
of the GFP positive cells was observed between 6 and 48
h post-electroporation (Figure 3f–h). The sigmoid shape
of GFP kinetics likely reflects the requirement for a pro-
gressive accumulation of the GFP signal in the transfected
cells to reach the detection threshold, combined with pro-
liferation of transfected progenitors. Interestingly, 6 h
after intraventricular injection/electroporation (20 V/50
ms/1 s/8 x) of stage 29/30 embryos, 36.7 ± 3.2% of the
Cell types and morphology of the transfected cells Figure 2
Cell types and morphology of the transfected cells. a: 
Membrane-tethered GFP (GAP-GFP) delineated the proc-
esses of transfected neurons including the axons (the ventri-
cle and neuropil are outlined in white). The arrow indicates a 
bundle of axons travelling in the neuropil). b: Radial-glia like 
morphology of GAP-RFP transfected cells lining the ventricle. 
c-e: Co-expression of GAP-GFP (c) and acetylated-tubulin 
(d) in superficial layers (e- merge). f: Wholemount brain 
preparation from an electroporated embryo showing differ-
ent axon tracts. The brain outline was drawn based on the 
corresponding bright field image. Di., diencephalon; OT, 
optic tectum; Tel., telencephalon; Epi., epiphysis. Scale bars: 
100 µm in f; 50 µm in a; 10 µm in b-e.
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Electroporation of stage 21–35/36 embryos leads to rapid expression of transgenes Figure 3
Electroporation of stage 21–35/36 embryos leads to rapid expression of transgenes. a: Electroporation efficiency 
decreased with increasing embryonic stage. Percentages of nls-GFP positive cells 12 h after transfection at stage 26, 28 or 32 (n 
represents the number of sections analyzed from 3 embryos). Similar results were obtained at 48 h post electroporation (data 
not shown). b-d: Distribution of transfected cells depended on the stage of embryos electroporated. Distribution of nls-GFP 
transfected cells 48 h afterwards in embryos electroporated at stage 28 (b) and 32 (c). Note that the density of cells (DAPI) is 
lower laterally. d: Histograms showing decreases in the fraction of cells transfected in the superficial third of the brain when 
embryos were electroporated at stage 32 as compared to stage 28. e: A cluster of superficially located cells can be selectively 
transfected by injecting the DNA solution under the skin (the pia and epidermis are outlined in white). f-h: Time course of GFP 
expression in embryos electroporated at stage 29/30 (20 V/25 ms/1 s/8 x). The fractions as well as mean intensities of GFP 
positive cells were quantified (h) from sections (examples: f and g) (15 sections from 3 embryos were analyzed for the 6 h and 
48 h time points and 39 sections from 3 embryos for the 24 h time-point). Differences between the time points were statisti-
cally significant using a Mann-Whitney test; probabilities are indicated together with the standard error (S.E.M). Outlines of the 
brains are presented (ventricle on the left). Scale bars: 100 µm in e; 50 µm in b, c, f and g.
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GFP positive cells were found in the superficial half of the
brain, suggesting that electroporation efficiently targets
both proliferating and differentiated cells. The wide range
of stages amenable to electroporation, combined with the
quick onset of transgene expression, demonstrates that
this technique provides precise temporal control.
Controlling spatial targeting to study axon guidance: the 
retino-tectal projection
The spatial selectivity allowed by electroporation has
proven useful for axon guidance studies [17,23,48-51].
Thus, using the well-characterized retinotectal projection
system, we next asked if our procedure could enable selec-
tive transfection of retinal ganglion cells (RGCs) and/or
the regions through which their axons travel. Normally,
axons from RGCs exit the eye, travel along the optic nerve
to enter the brain at the ventral diencephalon. After cross-
ing the midline at the optic chiasm, they extend dorsally
through the optic tract in the diencephalon before turning
caudally to reach the optic tectum, where they arborize
and form synapses.
Since only the region lying between the two electrodes is
efficiently electroporated, different areas can be selectively
electroporated by sliding the embryo forward or backward
in the main channel to expose the rostral or caudal part of
the head (Figure 4a and 4b). This configuration gives rise
to large transfected areas, extending rostro-caudally over
568 ± 40.5 µm (n = 13). Taking advantage of the insulat-
ing property of Sylgard, the electroporated region can be
restricted by narrowing the transverse channel (158 ± 17.6
× 89 ± 8.7 µm, n = 14), making specific electroporation of
the embryonic tectum or diencephalon feasible (Figure
4c–e). In addition, the relative orientation of embryos to
the electrodes can be changed to drive DNA towards dif-
ferent regions. Using modified chambers, the ventral-
most regions of the brain, which are usually difficult to
electroporate, can be targeted, allowing electroporation of
the optic chiasm region (Figure 4f and 4g).
To specifically electroporate the eye, embryos were placed
belly up so that the eye, but not the brain, was aligned
with the electrodes (Figure 4j). This avoided non-targeted
electroporation of the brain, which is important as the
lumen of the eye vesicle, where the DNA injection is
made, communicates directly with the brain ventricles at
early stages (Figure 4j insert and k). Eye specific electropo-
ration was successfully performed over a range of stages
from 22 to 35/36 without affecting eye development (Fig-
ure 4k, see additional file 1ee and 1ff [electroporated at
stage 24, 28 and 32 respectively]). The success rate, evalu-
ated 12 h after electroporation, was over 80%. 48 h after
electroporation, all layers of the retina were transfected
and cellular morphology within the retina appeared nor-
mal (Figure 4h and 4i). Interestingly, when eyes were elec-
troporated at stage 32, GFP-positive cells were widely
distributed in early stage 33/34 retina only 6 h after trans-
fection (see additional file 1cc and 1dd). Eye-targeted
electroporation yielded high levels of transgene co-expres-
sion when pCS2GFP and pCS2GAP-RFP plasmids were
injected in a 1:1 ratio. 95.4 ± 1.2% of the GFP positive
cells were RFP positive and 81.8 ± 3.1% of the RFP
expressing cells were also GFP positive (n = 313 and n =
366 cells respectively from 10 sections). More impor-
tantly, the co-electroporation efficiency remained high
even if different types of plasmids were mixed (Figure 4l–
n). Co-electroporation enables multiple perturbations as
well as easy monitoring of the transfected cells. Indeed,
RGC axons can be easily analyzed both in transverse sec-
tions (Figure 4k) and in the whole brain (Figure 4o) after
GAP-GFP electroporation. In addition, GAP-GFP transfec-
tion enables powerful time-lapse analysis of extending ret-
inal axons and growth cone dynamics to be performed in
vivo (Figure 4o–r) [52]. Fixed sample analysis as well as
live monitoring of GAP-GFP expressing RGC axons show
that electroporation does not perturb axonal growth, nav-
igation or branching. Thus, electroporation is suitable for
manipulating and monitoring RGC axons at stages when
lipofection has proven to be difficult.
Finally, we asked if both the eye and the pathway where
retinal axons grow (e.g. optic tract, optic tectum) could be
manipulated separately within the same embryo. We elec-
troporated eyes at stage 24 with GAP-RFP and brains 8 h
later at stage 30 with GAP-GFP. We found that dual-elec-
troporation produced specific expression both within the
eye and pathway. Importantly, dual electroporation did
not decrease embryo viability or cause abnormal develop-
ment (n = 21), and did not affect brain anatomy (see addi-
tional file 2ee). Furthermore, eye-specific electroporation
can be combined with either large or area-specific brain
electroporation (Figure 5a–d). Similarly, brain electropo-
ration was successfully performed on eye-lipofected
embryos (Figure 5e–g). Thus, dual-electroporation pro-
vides a way to separately control transgene expression in
the retinal axons versus the substrate pathway enabling in
vivo  analysis of axon-target and axon-pathway interac-
tions.
Targeted loading of antisense morpholinos by 
electroporation
In addition to DNA transfection, intracellular delivery of
antisense morpholinos (MOs) was tested. MOs are an
effective tool to knock-down protein expression in Xeno-
pus through blastomere injection [53,54] but their inabil-
ity to be taken up through the plasma membrane has
limited their use at late stages. Standard MOs are
uncharged and, therefore, cannot be electroporated. How-
ever, MOs can be fluorescently tagged for visualization
and, fortuitously, the tag introduces a charge makingBMC Developmental Biology 2007, 7:107 http://www.biomedcentral.com/1471-213X/7/107
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Using electroporation to study retino-tectal projections in vivo Figure 4
Using electroporation to study retino-tectal projections in vivo: a-b: Regions of the brain can be differentially targeted 
by sliding the embryo in the main channel (compare upper and lower panels in a). When the caudal part of the head was 
exposed, most of the optic pathway was electroporated (b). c-e: The transfected area can be restricted by reducing the 
amount of embryo area directly facing the electrodes. The modified chamber used to restrict electroporation is depicted in c 
(note the narrowing of the transverse channel in the inset), and a representative example of GFP expression 12 h post electro-
poration in a live embryo is shown in d. GFP expression in the tectum is shown on a wholemount dissected brain (e). Axons 
emanating from these neurons can be clearly observed (arrow). The dashed line delineates the diencephalon/mesencephalon 
boundary. The transfected area is restricted to the OT (dorsal mesencephalon). f-g: Electrodes can be placed dorsal and ven-
tral to the embryo to target the ventral or dorsal part of the brain. A frontal section through the midbrain (g) demonstrating 
that ventral populations can be targeted by placing the embryo on its side in the specifically designed chamber represented in f. 
h-r: Retinas can be electroporated without affecting eye development. 48 h post electroporation, GAP-GFP was detected in all 
the retinal layers and outlined different retinal cell types with their characteristic morphologies (h-i). Eye microanatomy 
appeared normal (h). Eye-targeted electroporation can be performed by placing the embryo ventral side up, so that the eye but 
not the brain faces the electrodes (j). Eye-specific electroporation can be performed with limited brain transfection. Insert: side 
view of a transfected embryo 24 h after eye-targeted electroporation. GFP signal was detected in the eye and the RGC axons 
navigating to the tectum (arrow) but not in the brain on frontal sections (k). l-n: Co-electroporation of pCS2GAP-RFP with 
pEGFP. Most of the GAP-RFP positive cells (m) are also EGFP positive (n). Double positive cells are marked with white dots 
and the arrows point to axons leaving the retina. Outlines of the retina and lens were drawn from the corresponding DAPI 
counterstainings. After GAP-GFP electroporation, axons can be monitored using time-lapse microscopy (o-q) and growth cone 
morphology can be analyzed (r) in wholemount brain preparations. Axons were monitored as they entered the tectum. Initial 
positions of the two growth cones are indicated (white dot and rectangle). Time is in hours. Epi., epiphysis. Scale bars: 400 µm 
in a, d and insert j; 200 µm in b and e; 100 µm in k; 50 µm in h, i and l; 25 µm in o-q; 10 µm in m and n; 5 µm in r.
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them amenable to electroporation [19]. Electroporation
of MOs in chick has been used to study nervous system
development, and single cell electroporation in the brain
of late-stage Xenopus embryos has been reported [12,19].
Lissamine-tagged MOs were electroporated into both the
brains and the eyes of stage 22 to 33/34 embryos with a
success rate of over 80% with all four settings used (20 V/
50 ms/1 s/8 x, 18 V/50 ms/1 s/10 x, 18 V/25 ms/1 s/10 ×
or 15 V/50 ms/1 s/10 x). In transverse sections, MO-
loaded cells were evenly distributed throughout the width
of the electroporated side of neuroepithelium, and along
most of its dorso-ventral axis (Figure 6a and 6b). With
eye-targeted electroporation, MO-positive cells were
found in all of the cellular layers of the retina (Figure 6c
and 6d). In all conditions tested, MO fluorescence was
still detectable 48 h after electroporation.
Plasmids were also successfully co-electroporated with
negatively charged MOs (both fluorescein- and special
delivery lissamine-tagged) (Figure 6e–g). For example, 48
h after eye-targeted electroporation (GFP 0.7 µg/µl [0.26
pmol/µl], MO 0.25 mM), 94.4 ± 1.4% of the GFP express-
ing cells were MO positive (n = 597 cells from 20 sections
from 3 embryos). However, in this condition the MO pos-
itive domain was slightly larger than the GFP-expressing
domain (Figure 6f), resulting in 65.4 ± 2.3 MO-loaded
cells expressing the GFP (n = 863 cells). Finally, as GFP
accumulates progressively the degree of co-localization
will change slightly with time and should be taken into
consideration.
At a cellular level, electroporated MOs seem to diffuse
evenly around the cytosol and into the nucleus. Although
short neuronal processes could be visualized with the MO
fluorescence, longer processes were usually so weakly
labeled that they were difficult to follow. However, co-
transfection with GAP-GFP highlighted axons emanating
from the electroporated RGCs, making monitoring of
axons from MO-loaded cells feasible (Figure 6g).
Both retinal projection neurons and their substrate pathway can be manipulated separately in the same embryo Figure 5
Both retinal projection neurons and their substrate pathway can be manipulated separately in the same 
embryo. a-d: Eye-targeted electroporation can be combined with brain electroporation. a: A dorsal view of an embryo doubly 
transfected. Retinal axons (red in b and c) navigate normally to the tectum, passing through a transfected region of the dien-
cephalon (green in c) (dashed line indicates the OT boundary). Eye- and ventral-targeted electroporation can be combined (d). 
Frontal section showing axons from the transfected retina (red) that have crossed the transfected midline (GFP-transfected) 
and growing dorsally towards tectum (arrow). e-g: Electroporation can be performed on embryos lipofected in the eyes. e: 
High magnification of two GFP lipofected axons passing through a cluster of electroporated tectal cells. f and g: Frontal sections 
of an embryo lipofected in the eye and electroporated in the brain. Retinal axons in the dorsal brain (green: f, g) traversed the 
transfected cells (red: g). Outlines of brains in wholemounts (b, c, e) and sections (f, g) were drawn based on bright field images 
and DAPI counterstainings respectively. Epi., epiphysis; Di., diencephalon; OT, optic tectum; Tel, telencephalon. Scale bars: 400 
µm in a; 100 µm in b-g.
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Introducing Morpholinos into young Xenopus tadpoles by electroporation and in vitro approaches Figure 6
Introducing Morpholinos into young Xenopus tadpoles by electroporation and in vitro approaches. a-d: Frontal 
sections of embryos 24 h after electroporation with lissamine-tagged MO. Large numbers of cells can be loaded with MO in 
both the brain (a) and the eye (c). Microanatomy of both structures appears normal (b and d). e-f: Co-electroporation of 
pCS2GAP-GFP with lissamine-tagged special delivery MO. e: A higher magnification image of a co-electroporated brain. The 
MO signal was de-saturated in Photshop in order to facilitate observation of MO and membrane GFP co-expression (arrow-
head). f: An image of eye-targeted co-electroporation illustrating the extent of co-electroporation and the sizes of MO and 
DNA electroporated regions. g: Frontal section of a MO/GFP co-electroporated embryo showing that GFP can be used to 
trace the axons of electroporated cells (arrowheads indicate axons at different points in their pathway). h and i: Examples of 
embryos electroporated with pCS2GFP in the presence (i) or absence (h) of anti-GFP MO. Morphology of the eye appeared 
normal in both conditions (left panel). The GFP signal was sharply reduced in the anti-GFP MO condition when analyzed 12 h 
after electroporation (central panels). A decrease in electroporation efficiency was not a confounding factor in this experiment 
as the Special Delivery lissamine-tagged MO control is efficiently loaded in both conditions (far right panel). j: Quantification of 
results presented in h and i (n indicates the number of embryos analyzed). Anti-GFP MO only affects expression of pCS2GFP 
but not of pEGFP (Clontech). k: Anti-GFP MO was co-electroporated with GFP and GAP-RFP. 48 h after electroporation, GFP 
and RFP fluorescence was quantified on sections and the ratio between the two calculated. (n refers to the numbers of sec-
tions quantified [3 embryos were analyzed for control and 6 for MO]). Statistical analysis: Mann-Whitney test; probabilities are 
indicated together with the S.E.M. l-m: Sections through an eye lipofected with GFP (green, l and m) and subsequently loaded 
with lissamine-tagged MOs (red) using electroporation (merge, m). n-q: Electroporated embryos can be a source of modified 
cells for in vitro studies. Explants and cells cultured from MO (n and o) or DNA (GFP) (p and q) electroporated embryos. Scale 
bars: 400 µm in h; 100 µm in a; 50 µm in d, f, and g; in 25 µm e and m; 20 µm in n; 10 µm in o.
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Finally, we took advantage of the high co-electroporation
efficiency to test the ability of the loaded MO to down-reg-
ulate translation of its target mRNA. A pCS2 plasmid
encoding GFP was electroporated with or without a MO
designed to block GFP expression [55]. Using this MO
directed against the pCS2+ and cytoplasmic GFP
sequences flanking the GFP start codon, we observed a 4-
fold decrease of the GFP signal both in the eye and the
brain when the MO against GFP was co-electroporated
with pCS2GFP (n = 24, n = 30 respectively, data not
shown). However, this decrease could be due to biased
electroporation and/or nonspecific effects of the anti-GFP
MO (such as cell death or general translation inhibition).
To rule out such problems, the experiments were per-
formed on the targetable (pCS2) and non-targetable GFP
(pEGFP) in the presence of a control tagged MO to assess
the electroporation efficiency. Co-electroporation of the
GFP MO only decreased the expression of the targetable
plasmid (Figure 6h–j). The decrease of the fluorescent
ratio of the GFP over GAP-RFP signal in the GFP MO elec-
troporated eyes further supports a specific effect of the
MO on the GFP (Figure 6k). In conclusion, our electropo-
ration procedure enables efficient loading of MOs without
impairing their activity in vivo. This suggests that, similar
to chick, controlled spatio-temporal MO knock-down
approaches could be achieved by electroporation in early
tadpole Xenopus  embryos. Furthermore, electroporation
allows sequential modifications of gene function when
used in combination with other techniques such as lipo-
fection (Figure 6l and 6m).
In vivo electroporation provides source of transfected/
MO-loaded neurons for in vitro studies
The embryonic Xenopus brain is extremely small, posing
challenges for obtaining a sufficiently large number of
cells to perform dissociated cell electroporation protocols
[56,57] and alternative transfection methods have low
efficiencies [58]. For example, MO uptake by Xenopus ret-
inal cultures is inefficient even when specific transmem-
brane trafficking molecules, such as Endo-Porter
(GeneTools) are used (data not shown). Thus, most Xeno-
pus transfected or MO-loaded cells used in culture have
been obtained from embryos injected at early blastomere
stages [59]. However, premature death or abnormalities
of injected embryos limit the spectrum of MOs or con-
structs that can be used to analyze later events in vitro.
Therefore, we cultured explants or dissociated cells from
different parts of brains electroporated with GAP-GFP
DNA and/or fluorescently tagged control MOs (fore-,
mid- or hind-brain). As shown in Figure 6n–q, both MO-
loaded and DNA transfected cells can be successfully cul-
tured and up to 40% of the cultured cells showed expres-
sion. Moreover, the positive-expressing explants and
dissociated cells were readily detected, even at low magni-
fications suggesting that intracellular levels of the MO and
the DNA were high. In culture, MOs could be readily seen
in axons and growth cones (Figure 6o), and could still be
detected after 2 days in vitro. This makes in vivo electropo-
ration a potent source of transfected cells for in vitro
approaches.
Conclusion
We describe here an optimized procedure to electroporate
different brain regions and the eye from stage 21 to 35/36
Xenopus  embryos. Both MOs and DNA were delivered
with high efficiency and with limited side effects. Electro-
poration enables both over-expression and knock-down
studies to be performed in a spatiotemporally controlled
manner. Furthermore, the high co-electroporation (DNA-
DNA or DNA-MO) efficiency makes perturbation of sev-
eral genes feasible and could be useful for identifying and
monitoring events in the MO or DNA electroporated cells
such as pathfinding or axon branching analysis. In addi-
tion, MO-DNA co-electroporation enables "rescue" exper-
iments to be performed. Finally, using different
electroporation protocols or DNA concentrations, expres-
sion levels can be kept low enough to avoid mis-localiza-
tion and/or toxicity of over-expressed markers, or
maximized to reach efficient concentration of dominant-
negative proteins.
The electroporation chambers we designed confer several
advantages. First, they enable a large number of embryos
to be electroporated rapidly in a reproducible way (1–3
min per embryo). Chambers can be readily made to fit
embryos of different ages, and appropriate placement of
the embryo within the chamber allows different parts of
the developing nervous system to be targeted. Further-
more, chambers can also be made to accommodate
zebrafish embryos for which electroporation protocols
have been recently developed (see additional file 2a–ca-c)
[30,31]. Thus, our method has a wide range of prospective
applications, both in Xenopus  and in other organisms.
Indeed, targeting of various other regions of interest for
axon guidance (telencephalon, spinal cord) and double
brain-targeted electroporations were successfully per-
formed (see additional file 2d–id-i).
One main advantage of our protocol is that electropora-
tion can be controlled spatiotemporally, which means
that secondary defects arising from early gene manipula-
tions can be avoided. Indeed, the present protocol pro-
vides the degree of targeting precision (around 150 µm2)
required to selectively electroporate eye or brain regions
in  Xenopus  embryos. As electroporation efficiency
remained high at all the stages tested, the described
parameters can be used to investigate gene function at a
critical time for nervous system development. Electropo-
ration also leads to quicker detectable expression of the
DNA than most available techniques [9,11,12]. This rapidBMC Developmental Biology 2007, 7:107 http://www.biomedcentral.com/1471-213X/7/107
Page 12 of 16
(page number not for citation purposes)
onset of transgene expression is particularly useful since in
many cases only several hours are needed for an axon to
complete its growth. As RNA can be successfully electro-
porated (data not shown), the delay between electropora-
tion and protein expression could be further shortened.
Finally, spatiotemporal control of expression could be fur-
ther refined by using specific promoters [38].
Lastly, electroporation of previously electroporated or
lipofected embryos enables sequential modification of
the same region, or a combination of specific modifica-
tions of both neurons and the environment through
which their axons navigate. The ability to genetically
manipulate both the presynaptic neurons and the path-
way/targets of their axons in the same embryo will pro-
vide a valuable new experimental paradigm for
investigating axon-pathway and axon-target interactions
in vivo and in vitro. For instance, co-electroporation of suit-
able makers in double transfected embryos may provide
unique insights into the cellular interaction in vivo
between axons and the environment, or between axon ter-
minals and their synaptic partners.
Methods
Animals
Oocytes obtained from adult female Xenopus laevis
injected with human chorionic gonadotropin hormone
(Sigma) were fertilized in vitro. Embryos were raised in
0.1× MBS until they reached the desired stage. Stages were
determined according to Nieuwkoop and Faber [60].
Plasmids and Morpholinos
Expression plasmids pCS2GAP-GFP and RFP [61,62],
pCS2GFP [8,55], pCS2nls-GFP [63], pEGFP (Clontech)
were prepared from Escherichia Coli cultures using the Qia-
gen Midi DNA preparation kit (Qiagen) and resuspended
in water. When concentrations above 3 µg/µl were
required, the plasmid preparations were concentrated by
isopropanol precipitations.
Morpholino oligonucleotide paired to a complementary
carrier DNA (Special Delivery) directed against the
pCS2GFP was a gift from M. Perron [55]. Crude and Spe-
cial Delivery standard control (Ctr) MOs (5'CCTCTTAC-
CTCA-GTTACAATTTATA3') fluorescently tagged with
lissamine (liss) or carboxyfluorescein were purchased
from GeneTools. 1 mM stock solutions were prepared and
stored at -20°C. Stock solutions were heated at 65°C for
5 min prior to dilution.
Electroporation chamber
The electroporation chambers consist of two intersecting
channels carved in the shape of a "†" in a 0.8 cm layer of
silicon elastomer coating the bottom of a 35 mm plastic
petri dish (Sylgard 184, Dow Corning, USA) (see addi-
tional file 3). This material (Sylgard) was preferred over
others by virtue of its mechanical resilience and electrical
resistance. Sylgard is sufficiently stable to allow repetitive
use of the chamber and soft enough to ensure that
embryos are not damaged when placed carefully into the
chamber. A total of 8 out of 34 chambers originally tested
were selected. The selected chambers were successfully
reproduced from negative imprints of the original ones
and copies can be provided upon request (see additional
file 3). The geometry of the chamber varies depending on
the stage and targeting (see additional file 4a). For stage
28–30 embryos, the longitudinal channel is 7 mm long, 1
mm wide and has a maximal depth of 1 mm. The trans-
verse channel, at the ends of which electrodes should be
placed, is 4 mm long, 0.8 mm wide and 0.2–0.5 mm deep.
Electroporation Protocol
Embryos had their vitelline membrane removed and were
placed in fresh 0.1× MBS before being anaesthetized in
the electroporation medium (0.4 mg/ml MS222 in 1×
MBS or 1× MMR). 1× MMR: 100 mM NaCl/2 mM KCl/1
mM MgSO4/2 mM CaCl2/5 mM Hepes/1 mM EDTA. 1×
MBS: 88 mM NaCl/1 mM KCl/2.4 mM NaHCO3/10 mM
Hepes/0.8 mM MgSO4/0.33 mM Ca(NO3)2/0.4 mM
CaCl2. Anaesthetized embryos were individually trans-
ferred into the transfection chamber in a drop of medium,
placed into the main channel of the chamber and excess
medium was gently removed. Homemade flat-ended 0.5
mm wide platinum electrodes (Sigma, 26788-1G, see
additional file 4b and 4c) were placed into the transverse
channel.
Pulled borosilicate glass capillaries (1 mm OD-0.78 ID,
GC100TF10, Harvard Apparatus; puller Pul-1, World Pre-
cision instrument) were back-filled with MO (0.1–0.5
mM in water) and/or DNA solutions (0.5–2.5 µg/µl in
water). In the case of the subcutaneous injections, higher
DNA concentrations were used (3–6 µg/µl). In some
cases, methylcellulose was added to limit the diffusion of
the injected solution and to increase the targeting [46].
Fast Green was added to DNA but not to MO solutions as
it has been shown to inhibit MO electroporation [19]. The
injection capillary tip was positioned so that the targeted
region lay inbetween the tip and the positive electrode.
Depending on the stage, 100–300 nl (subcutaneous), 50–
100 nl (intraventricular) or 10–30 nl (eye specific) of
DNA(s) and/or MO solution was injected using an air-
pressured injector (Picospritzer II, Intracel). The tip of the
capillary was broken with fine forceps under a stereomi-
croscope so that it released 5–8 nl per pulse. The capillary
was removed just before the first electric pulse of the series
was delivered by the square wave pulse generator (TSS20
OVODYNE electroporator, Intracel). After the pulse series
was completed, the electrodes were removed and theBMC Developmental Biology 2007, 7:107 http://www.biomedcentral.com/1471-213X/7/107
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embryo gently collected from the chamber in a large drop
of electroporation medium. Electroporated embryos were
then placed in sterile 0.1× MBS and grown at 18°C. To
avoid damage due to handling, embryos were moved with
large round-tip glass tools and were transferred in and out
of the chamber with a large plastic pipette. Both the capil-
lary and electrodes were manipulated using manual
micromanipulators (Fine Science Tools).
Brain Sections, DAPI and TUNEL staining and image 
processing
Embryos were fixed with 4% PFA in PBS over night at 4°C
and then rinsed with PBS. Subsequently, fixed embryos
were equilibrated in 15% then 30% sucrose/PBS solutions
and embedded in Tissue-Tek OCT compound (Sakura).
10 µm cryostat sections were collected on Superfrost slides
(VWR) and dried for 60 min prior to staining. Sections
were post-fixed in ethanol/acetic acid (2/1 volumes) for 5
min at -20°C prior to TUNEL labeling. TUNEL labeling
(Apoptag fluorescein kit S7110, Intergen Company) was
performed according to the manufacturer's recommenda-
tions. The sections were incubated in DAPI at 1/10000
(D9542, Sigma) for 5 min in 0.1% Triton/1× PBS at room
temperature (RT) and washed 3 times in PBS before
mounting. Blocking was done with 1% BSA/10% Goat
serum/0.1% Triton in 1× PBS for 30 min at RT. For labe-
ling of differentiated neuronal cells, the sections were
incubated with anti-acetylated tubulin (6-11B-1, Zymed,
stock: 0.5 mg/ml) for 2 h at RT (1/200 in the blocking
buffer) and visualized with a Cy3 anti-mouse secondary
antibody (AP 124C, Chemicon) (1/1000 in the blocking
buffer).
Sections were mounted in Fluorosave medium (Calbio-
chem), and photographed. All images were acquired from
grayscale cameras (ORCA-ER, Hamamatsu) using Open
lab software (Improvision) and processed in Photoshop
(Adobe). For TUNEL quantification, all TUNEL labeling
co-localizing with DAPI positive structures in the brain
were counted on sections (where the eye was present). The
statistical analysis was performed in InStat3 (Graphpad
Software Inc).
Evaluation of the transfection efficiency
For testing the electroporation parameters, embryos from
different test conditions were injected with the same vol-
ume using the same capillary. Electroporation using the
standard setting (20 V/50 ms/1 s/8 x) was always per-
formed at the end of the test series as a control.
12 h after electroporation, the success rate was estimated
on live anesthetized embryos under a fluorescence stereo-
scopic microscope (MZFLII, Leica). Each embryo was
scored according to the fluorescence intensity and spread
of the signal (0 = no signal, 0.25 = dim, 0.5 = high but
restricted, 1 = high and widespread). As absolute effi-
ciency varies with DNA preparations and embryo batches,
embryos electroporated with the standard setting were
scored first to set the index. Results from different experi-
ments were normalized to the standard settings (100%).
The pictures presented and archived were taken under the
same conditions (same magnification, time after electro-
poration and exposure). Embryos exhibiting any apparent
damage such as smaller eye, local head depression, defect
in eye pigmentation or persistent skin peeling were scored
as damaged.
The fraction of transfected cells was quantified on serial
frontal sections of embryos 6 h, 12 h, 24 h or 48 h after
electroporation with nls-GFP. Sections were screened at
low power (5×) to identify the rostral most and caudal
most positive sections. All inclusive sections were then
photographed at 20× (Eclipse 80i, Nikon) using fixed
acquisition parameters separately set for the 24 h (for
analysis of electroporation kinetics) and 12 h (for analysis
of stage and pulse parameters) time points (Orca, Hama-
matsu, Open lab, Improvision). Regions of interest (ROIs)
corresponding to the hemi-neural tube and superficial
regions of the brain were outlined based on DAPI counter-
staining and used for subsequent quantification. Thresh-
olds were set for DAPI and GFP fluorescence intensity and
the total area in ROIs above threshold was calculated.
Thresholds for DAPI and GFP were calibrated so that the
ratio of GFP area to DAPI area matched the manual per-
centage count at 24 h (kinetics) or 12 h (stages and pulse
parameters). The centers of mass of DAPI and GFP signals
were also calculated. All the quantifications were done in
ImageJ (NIH).
Morpholino knock-down of GFP expression
Embryos were injected separately with: (1) 0.7 µg
pCS2GFP or 0.7 µg pCS2GFP+0.33 mM GFPMO (eye and
brain); (2) 0.7 µg pCS2GFP+0.1 mM liss-CtrMO, 0.7 µg
pCS2GFP+0.33 mM GFPMO+0.1 mM liss-CtrMO, 0.7 µg
pEGFPC1+0.1 mM liss-CtrMO or 0.7 µg pEGFPC1+0.33
mM GFPMO+0.1 mM liss-CtrMO (eye); (3) 0.7 µg
pCS2GFP+0.7  µg GAP-RFP or 0.7 µg pCS2GFP+0.7 µg
GAP-RFP+0.33 mM GFPMO (eye).
12 h after electroporation, images of intact living embryos
were acquired and levels of GFP expression were quanti-
fied. For the first set of experiments (1), the integral of
GFP fluorescence was calculated for the eye region. For the
second set (2), a circular ROI encompassing the eye was
drawn from the corresponding bright-field pictures and
used to determined the mean intensity level of the red
(electroporation control) and green (GFP expression)
channels. The green to red ratio was calculated for all
embryos that exhibited a mean fluorescence intensity overBMC Developmental Biology 2007, 7:107 http://www.biomedcentral.com/1471-213X/7/107
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background threshold in the red channel. All acquisitions
and quantifications were done blind.
In the third set of experiments (3), the expression of GFP
and GAP-RFP was measured on serial coronal sections 48
h after electroporation. Images were acquired and thresh-
olds were set identically between the conditions and the
GFP/GAP-RFP ratio was calculated. All quantifications
were performed in ImageJ and all statistical analysis was
done in InStat3 (Graphpad Software Inc).
Electroporation of lipofected or electroporated embryos
Stage 19–20 eye primordia were lipofected as described
previously with GAP-GFP plasmid mixed with DOTAP
(Roche) [8]. These lipofected embryos were then electro-
porated with GAP-RFP at stage 28 as described above.
Embryos first electroporated at stage 24 or 28 (GAP-RFP)
were allowed to recover at room temperature for several
hours before being electroporated at stage 29/30 or 32
(GAP-GFP).
Time-lapse in vivo microscopy
Electroporation was performed on stage 28 embryos using
the standard protocol. When reaching stage 39, embryos
were anaesthetized and prepared for live imaging as
described previously [64]. Briefly, the eye and skin cover-
ing the contralateral brain were removed to expose the
transfected axons. The embryo head was placed in 0.05
mg/ml MS222/1× MBS filled chamber formed by a gene
frame (ABGene, AB 0576) placed on an oxygen permeable
slide (Permanox, Nalgen Nunc, 16005). Only samples
with a few isolated axons were selected for subsequent live
imaging. Image acquisition was performed on a Nikon
Optiphot-2 microscope equipped with a 20× Plan
NeoFluar objective and Orca-ER cooled CCD camera
(Hammamatsu). To minimize phototoxicity, acquisitions
were made with neutral density filters on and short expo-
sure times (50–100 ms). Z-stacks were acquired every 10
min.
Cell culture
14 h-20 h after electroporation, brains (fore-, mid-, and
hind-brain) and eyes were dissected from electroporated
embryos [65] and cut into 2–4 explants. In the case of dis-
sociated primary cultures, tissues from embryos under
stage 30 were dissociated in calcium free medium (0.4
mM EDTA) [66] using fire polished Pasteur pipettes. For
embryos older than stage 30, their tissues were incubated
for 6–8 min in trypsin solution (Gibco) before being
mechanically dissociated. The trypsin was inactivated in
10 times its volume of 10% FBS medium prior to tritura-
tion. Both explants and dissociated cells were cultured in
60% L15/10% FBS/1% PSF (100 U/ml penicillin, 100 µg/
ml streptomycin and 0.25 µg/ml fungizone; Gibco) on
glass coverslips coated with 100 µg/ml poly-L-lysine
(Sigma) and 10 µg/ml laminin (Sigma). The cultures were
analyzed 24 h and 48 h after plating.
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